BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

VinBrain and Global Fund Partner to Fight Tuberculosis in Vietnam with AI in 2024

VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain's in...

February 29, 2024 | News

TechInvention Lifecare Starts Building Advanced Global Health Solutions Center

GCMC has been acknowledged for its global significance at the 2nd World Local Production Forum in The Hague on 6-8 November 2023, organized by the ...

February 29, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

February 26, 2024 | News

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...

February 19, 2024 | News

AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand

AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...

February 19, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

February 19, 2024 | News

Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)

Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...

February 17, 2024 | News

STARmed Expedites Global Rollout of EUSRA and ELRA Products in Collaboration with Olympus

Previously distributed by Taewoong Medical Co., Ltd., a Korean gastrointestinal medical device manufacturer, EUSRA and ELRA products will n...

February 16, 2024 | News

FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...

February 15, 2024 | News

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

February 14, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...

February 13, 2024 | News

Stay Connected